• Search History (Register)
  • MeSH Browser
Sort by Relevance
Search Results [1476 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2012 Institut national d'excellence en sante et en services sociaux (INESSS) [Immunochemical fecal occult blood. Determination of a positivity threshold for the upcoming demonstration projects under Québec's colorectal cancer screening program]
2012 Institut national d'excellence en sante et en services sociaux (INESSS) [Specialized services for people with alzheimer's disease]
2012 Agency for Healthcare Research and Quality (AHRQ) Screening and diagnosing gestational diabetes mellitus
2012 Agency for Healthcare Research and Quality (AHRQ) Multigene panels in prostate cancer risk assessment
2012 Agency for Healthcare Research and Quality (AHRQ) Diagnosis and management of febrile infants (0–3 months)
2012 NIHR Horizon Scanning Centre (NIHR HSC) SCOUT DS® and Diab-spot for type 2 diabetes screening
2012 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [HIV screening in the general population]
2012 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Screening for colorectal cancer part 1: screening-tests and program design
2012 Andalusian Health Technology Assessment Area (AETSA) [Extended neonatal screening for lysosomal diseases by mass spectrometry]
2012 Andalusian Health Technology Assessment Area (AETSA) [Rapid tests for methicillin resistant Staphylococcus aureus. Carrier screening. Executive summary]
2012 HAYES, Inc. Harmony™ Prenatal Test
2012 HAYES, Inc. Radioactive seed localization (RSL) of nonpalpable breast lesions for surgical excision
2012 Agency for Healthcare Research and Quality (AHRQ) Noninvasive diagnostic tests for breast abnormalities: update of a 2006 review
2012 Agency for Healthcare Research and Quality (AHRQ) Fecal DNA testing in screening for colorectal cancer in average-risk adults
2012 Agency for Healthcare Research and Quality (AHRQ) Screening for glaucoma: comparative effectiveness
2012 HAYES, Inc. Screening, brief intervention, and referral to treatment (SBIRT) for substance use among pregnant women
2012 HAYES, Inc. Breast-specific gamma imaging (BSGI) using the dilon 6800 gamma camera (Dilon Technologies Inc.)
2012 HAYES, Inc. EarlyCDT-lung risk assessment test (Oncimmune [USA] LLC)
2012 Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Economic evaluation of the introduction of the HPV vaccine in Spain to prevent cervical cancer]
2012 HAYES, Inc. Selenia dimensions digital tomosynthesis system (Hologic Inc.) for diagnostic mammography
2012 HAYES, Inc. Ki-67 (MKI67) proliferation marker testing in ductal carcinoma in situ (DCIS) and breast cancer
2012 Andalusian Health Technology Assessment Area (AETSA) [Heterochromatic flicker photometry for the detection of the risk of age-related macular degeneration]
2012 Andalusian Health Technology Assessment Area (AETSA) [Digital tomosynthesis of the breast]
2012 Penn Medicine Center for Evidence-based Practice (CEP) Guidelines for use of screening and preventive services
2012 Scottish Health Technologies Group (SHTG) What is the clinical and cost effectiveness of human papillomavirus (HPV) testing, followed by liquid-based cytology triage of positive results, in primary screening for cervical cancer?
2012 Scottish Health Technologies Group (SHTG) High-risk human papillomavirus (HPV) testing as triage for women with mild or borderline cytology abnormalities
2012 National Evidence-based Healthcare Collaborating Agency (NECA) [A research on evidence-based healthcare for thyroid cancer screening: Part 2: Effectiveness of ultrasonographic screening for thyroid cancer]
2012 National Evidence-based Healthcare Collaborating Agency (NECA) [A research on evidence-based healthcare for thyroid cancer screening: Part 1: the current status of thyroid cancer screening]
2012 Health Information and Quality Authority (HIQA) Economic evaluation of repeat universal antenatal screening for HIV in the third trimester of pregnancy
2012 Agency for Healthcare Research and Quality (AHRQ) Screening for HIV in pregnant women: systematic review to update the U.S. Preventive Services Task Force Recommendation.
2012 Agency for Healthcare Research and Quality (AHRQ) Screening for HIV: systematic review to update the U.S. Preventive Services Task Force Recommendation
2012 Agency for Healthcare Research and Quality (AHRQ) Screening women for intimate partner violence and elderly and vulnerable adults for abuse: systematic review to update the 2004 U.S. Preventive Services Task Force Recommendation.
2012 Agency for Healthcare Research and Quality (AHRQ) Screening for hepatitis C virus infection in adults
2012 Agency for Healthcare Research and Quality (AHRQ) Screening, behavioral counseling, and referral in primary care to reduce alcohol misuse
2012 Agency for Healthcare Research and Quality (AHRQ) Chronic kidney disease stages 1–3: screening, monitoring, and treatment.
2012 Institute for Clinical Effectiveness and Health Policy (IECS) [Photodynamic therapy for non-melanocytic skin cancer treatment]
2012 Institute for Clinical Effectiveness and Health Policy (IECS) [Combined screening for early diagnosis of chromosomal abnormalities during the first trimester of pregnancy]
2012 Institute for Clinical Effectiveness and Health Policy (IECS) [Catheter-directed mechanical thrombolysis in thromboembolic disease]
2012 Health Council of the Netherlands Gezondheidsraad (GR) Population Screening Act: accelerated repeat screening for bowel cancer
2012 Health Council of the Netherlands Gezondheidsraad (GR) Population Screening Act: tuberculosis screening
2012 Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Systematic Review of the efficacy, effectiveness, safety and cost of Preimplantational Genetic Screening]
2012 Institute of Health Economics (IHE) The effectiveness and safety of preschool hearing screening programs
2012 Institute of Health Economics (IHE) The safety and effectiveness of preschool vision screening
2012 Institute of Health Economics (IHE) The safety and efficacy/effectiveness of using automated testing devices for universal newborn hearing screening: an update
2012 HTA Unit, University of Calgary A health technology assessment of transient elastography in liver disease
2012 Malaysian Health Technology Assessment (MaHTAS) Point-Of-Care test for Chlamydia
2012 Basque Office for Health Technology Assessment (OSTEBA) [Evaluation of the implementation of clinical guidelines in the Basque Country. Cluster randomized trial]
2012 Basque Office for Health Technology Assessment (OSTEBA) [Seroprevalence of Trypanosoma Cruzi infection in Latin American women of fertile age and during pregnancy in the Autonomous Community of the Basque Country]
2012 Basque Office for Health Technology Assessment (OSTEBA) [Cost evaluation of the early breast cancer detection programme of the Autonomous Community of the Basque Country]
2012 Basque Office for Health Technology Assessment (OSTEBA) [Validation of a malnutrition screening tool useful in a general hospital]
2012 Basque Office for Health Technology Assessment (OSTEBA) [Diagnosis and consumption of drugs for Alzheimer's disease in the Basque country]
2012 Health Sciences Institute in Aragon (IACS) Programme activities for early detection of health problems between 0 and 14 years old. Effectiveness, safety and economic evaluation of the different alternatives in the early detection of hip dysplasia in newborns
2012 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Information, consent and medical counselling on ultrasound screening in pregnancy]
2012 Canary Health Service [Cost-effectiveness of expanded newborn screening by mass spectrometry]
2012 Canary Health Service [Cost-effectiveness of newborn screening for cystic fibrosis]
2011 German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Benefit assessment of HPV testing in primary screening for cervical cancer]
2011 Health Council of the Netherlands Gezondheidsraad (GR) [Population screening for cervical cancer]
2011 The Netherlands Organisation for Health Research and Development (ZonMw) [Cost-effectiveness of nutritional screening and intervention in elderly subjects after hip fracture]
2011 NIHR Health Technology Assessment programme MAVARIC - a comparison of automation-assisted and manual cervical screening: a randomised controlled trial
2011 NIHR Health Technology Assessment programme Growth monitoring for short stature: update of a systematic review and economic model
2011 The Swedish Council on Health Technology Assessment (SBU) [Computer-Aided Detection (CAD) in mammography screening]
2011 Health Information and Quality Authority (HIQA) A health technology assessment of prion filtration of red cell concentrates to reduce the risk of variant Creutzfeldt-Jakob disease transmission in Ireland
2011 Agency for Healthcare Research and Quality (AHRQ) Diagnosis and treatment of obstructive sleep apnea in adults
2011 Health Intervention and Technology Assessment Program (HITAP) [Cost-benefit analysis of prenatal screening and diagnosis for Down syndrome in Thailand]
2011 Health Intervention and Technology Assessment Program (HITAP) [School-based screening for Attention Deficit and Hyperactivity Disorder (ADHD) and Learning Disorders (LD)]
2011 Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS) Prostate cancer screening
2011 Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS) Nasopharyngeal carcinoma screening
2011 Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS) HPV DNA-based screening test for cervical cancer
2011 Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS) Immunochemical faecal occult blood test (IFOBT) for colorectal cancer screening
2011 Agency for Healthcare Research and Quality (AHRQ) Screening for hearing loss in adults ages 50 years and older: a review of the evidence for the U.S. Preventive Services Task Force.
2011 Agency for Healthcare Research and Quality (AHRQ) Screening for visual impairment in children ages 1-5 years: systematic review to update the 2004 U.S. Preventive Services Task Force Recommendation
2011 Agency for Healthcare Research and Quality (AHRQ) Traumatic brain injury and depression.
2011 Canadian Agency for Drugs and Technologies in Health (CADTH) Octaplas compared with fresh frozen plasma to reduce the risk of transmitting lipid-enveloped viruses: an economic analysis and budget impact analysis
2011 HAYES, Inc. Full-field digital mammography for breast cancer screening
2011 HAYES, Inc. Transvaginal ultrasound for measurement of cervical length to predict preterm birth
2011 Canadian Agency for Drugs and Technologies in Health (CADTH) Point of care cholesterol testing for coronary heart disease: a review of the clinical effectiveness and guidelines
2011 Canadian Agency for Drugs and Technologies in Health (CADTH) Screening and assessment tools for patients with chronic disease in therapeutic exercise program: a review of the clinical evidence and guidelines
2011 Canadian Agency for Drugs and Technologies in Health (CADTH) Auditory screening and hearing loss prevention: a review of the clinical evidence and guidelines
2011 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Reorientation of the Austrian parent-child preventive care programme. Part II: international policies, approaches and screening strategies to "normal" and "risk experiences" during pregnancy and early childhood to school entry]
2011 The Regional Health Technology Assessment Centre (HTA-centrum) Pulse oximetry (POX) screening for congenital heart defects in newborns
2011 HAYES, Inc. Rapid antibody tests for HIV screening
2011 HAYES, Inc. Genetic testing for dilated cardiomyopathy (DCM)
2011 HAYES, Inc. TP53 (p53) testing for Li-Fraumeni Syndrome (LFS)
2011 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Implementation of quality indicators to assess the high risk of colorectal cancer clinic]
2011 Haute Autorite de sante (HAS) [A priori evaluation of the expansion of newborn screening to one or more inborn error(s) of metabolism using the technology of tandem mass spectrometry in the general population in France. Part 1: medium chain CoA dehydrogenase deficiency (MCADD)]
2011 Penn Medicine Center for Evidence-based Practice (CEP) Brief screening tests for depression in emergency patients
2011 HAYES, Inc. MaterniT21™ Noninvasive prenatal test for trisomy 21 (Down Syndrome)
2011 HAYES, Inc. Tay-Sachs Disease (TSD) testing in individuals of non–ashkenazi jewish origin
2011 Agency for Healthcare Research and Quality (AHRQ) Screening and treatment of subclinical hypothyroidism or hyperthyroidism
2011 Andalusian Health Technology Assessment Area (AETSA) [Prenatal screening for aneuploidy using free fetal DNA in maternal blood. Systematic review of the literature.]
2011 Scottish Health Technologies Group (SHTG) What is the clinical and cost effectiveness of the ThinPrep imager® (HologicTM, Inc) for assisted cervical cytology compared with manual reading of liquid based cytology slides?
2011 Institute for Clinical Effectiveness and Health Policy (IECS) [Carotid echo doppler for plaque area measurement in cardiovascular risk stratification]
2011 Health Council of the Netherlands Gezondheidsraad (GR) Population screening act: prostate cancer screening using MRI
2011 Haute Autorite de sante (HAS) [Assessment of glomerular filtration rate and serum creatinine levels in the diagnosis of chronic kidney disease in adults]
2011 Haute Autorite de sante (HAS) [Albumin (or protein) to creatinine ratios in the diagnosis of chronic kidney disease in adults]
2011 Haute Autorite de sante (HAS) [Biology of haemostasis disorders: lupus anticoagulant detection]
2011 Basque Office for Health Technology Assessment (OSTEBA) [Digital mammograms in breast cancer screening. Assessment of their efficiency and inclusion in the Early Breast Cancer Detection Programme of the Basque Country]
2011 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Fact sheet: Screening for gestational diabetes - rapid report]
2011 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Screening for defined speech and language development disorders in children: Appraisal of the KiSS.2 study]
2011 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Benefit assessment of HPV test in primary screening for cervical cancer]